How Clincase’s Hybrid Methodology Keeps EDC Implementation Agile, Focused, and On Track
Every successful clinical trial starts with a team that knows how to turn complex protocols into working systems. At Clincase, we use a hybrid project management methodology that blends structure and flexibility to guide EDC implementation from planning through go-live. In this article, developed with our Implementation Manager, Caroline Chong, we explain how her team supports sponsors and CROs by delivering setups that align with operational workflows and meet regulatory requirements.
Why Choosing the Right EDC System Is Critical for Clinical Trial Success
Clinical trials are growing more complex — not just scientifically, but operationally. As protocols evolve and timelines tighten, mid-sized CROs must deliver faster, more tailored trials with leaner teams. Choosing the right EDC system is critical to keeping pace and staying competitive.
ACDM 2025 Recap: Innovation, AI, and Reconnecting with the Data Management Community
The ACDM Conference 2025 in Prague, held from 2 to 4 March, brought together representatives from over 180 organizations in the clinical data management community to learn, share, and network. With a packed two-day program, pre-conference workshops, and insightful discussions, the event served as a hub for industry experts to explore the latest advancements in clinical data management. Featuring world-class speakers, hands-on workshops, and valuable networking opportunities, ACDM25 fostered meaningful discussions that are shaping the future of clinical trials.
Beyond Inclusion: Addressing Data Gaps in Women’s Healthcare
In recent years, clinical trials have made progress in improving gender representation, but inclusion alone is not enough. The real challenge lies in how data is captured, analyzed, and applied—ensuring that research accounts for the biological, hormonal, and metabolic differences between men and women. Without structured, meaningful data collection, critical insights are missed, and healthcare outcomes remain unequal.
Decentralized Trials Must Put Patients First—Not Just Technology
At EUCROF 2025 in Copenhagen, Monique Dugueperoux, our Business Development Manager, attended a panel discussion on home trial services, where key stakeholders—sponsors, patients, sites, CROs, and health authorities—shared insights on the future of decentralized clinical trials (DCTs).
Celebrating Singapore-Germany Partnership at the Chinese New Year Reception
The Chinese New Year reception at the Singapore Embassy in Berlin was a special occasion for the Singaporean community in Germany to come together and celebrate the Year of the Snake. Our founders, Henning and Judy, joined the festivities and had the honour of meeting Singapore’s Deputy Prime Minister, Mr. Heng Swee Keat, to exchange insights on economic transformation, innovation, and cross-border collaboration.
Optimizing Preset Templates for Local Lab Management
In our continued effort to simplify clinical workflows and improve data accuracy, we’re proud to introduce a series of updates to the Local Lab module’s template management functionality, rolled out at the beginning of this year. These enhancements are designed to streamline workflows and support the operational efficiency of clinical teams, statisticians, and project managers.
Clincase’s Streamlined Study Build Process
At Clincase, we know that every successful clinical trial begins with a strong foundation. Our streamlined study build process is designed to address the complexities of clinical research while tailoring solutions to meet your unique needs. With trusted collaboration and advanced tools, we help your trial succeed from day one.
Clincase ePRO Expands Eastern European Language Support
Our commitment to patient-centric clinical trials continues with the expansion of our ePRO language support across Eastern Europe. Building on our existing support for Polish, Clincase ePRO now enables participants to navigate the entire interface—along with questionnaires, updates, and real-time study interactions—in their native languages, such as Hungarian, Bulgarian, Estonian, Georgian, Russian, Romanian, and Ukrainian. This language inclusion aims to reduce barriers and enhance patient engagement, particularly in Decentralized Clinical Trials (DCTs).